Article Text
ABN News
ABN news
Statistics from Altmetric.com
Although writing this in August 2023, it is the morning after half a month’s rain fell in the space of a few hours overnight with gale force winds into the bargain. All par for the course in an English summer. Naturally, being in a tent on the South Coast did not help the unseasonable feeling. Although we always feel the grass is metaphorically greener elsewhere, the grass is at least literally greener here in the UK.
By the time you read this, the inaugural ‘Preparing for Consultancy’ Course run by the ABN will have happened. We rightly focus so much on …
Read the full text or download the PDF:
Other content recommended for you
- Differential levels of plasma biomarkers of neurodegeneration in Lewy body dementia, Alzheimer’s disease, frontotemporal dementia and progressive supranuclear palsy
- Neuropathology and emerging biomarkers in corticobasal syndrome
- Genetics of Parkinson’s disease and related disorders
- Beyond and below the cortex: the contribution of striatal dysfunction to cognition and behaviour in neurodegeneration
- Serum neuronal exosomes predict and differentiate Parkinson’s disease from atypical parkinsonism
- Neuropsychological follow up in patients with Parkinson's disease, striatonigral degeneration-type multisystem atrophy, and progressive supranuclear palsy
- Midcingulate involvement in progressive supranuclear palsy and tau positive frontotemporal dementia
- Survival in progressive supranuclear palsy and frontotemporal dementia
- An evaluation of the impact of MAPT, SNCA and APOE on the burden of Alzheimer's and Lewy body pathology
- Stiff person syndrome